Spinal Muscular Atrophy Genetic Testing Experience at an Academic Medical Center-Reference-Cited by-同舟云学术

Spinal Muscular Atrophy Genetic Testing Experience at an Academic Medical Center

Published:2002-02 Issue:1 Volume:4 Page:53-58
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Ogino Shuji,Leonard Debra G.B.,Rennert Hanna,Wilson Robert B.

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference32 articles.

1. International SMA consortium meeting (June 26–28, 1992, Bonn, Germany);Munsat;Neuromuscul Disord,1992

2. Spinal muscular atrophy: clinical and genetic correlation;Zerres;Neuromuscul Disord,1997

3. Use of genetic and physical mapping to locate the spinal muscular atrophy locus between two new highly polymorphic DNA markers;Clermont;Am J Hum Genet,1994

4. Refinement of the spinal muscular atrophy locus to the interval between D5S435 and MAP1B;Soares;Genomics,1993

5. De novo and inherited deletions of the 5q13 region in spinal muscular atrophies;Melki;Science,1994

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy in pediatrics – Clinical studies and approved drugs (as of 2023);Life Sciences;2024-07

2. Studying carrier frequency of spinal muscular atrophy in the State of Qatar and comparison to other ethnic groups: Pilot study;Molecular Genetics & Genomic Medicine;2023-11-15

3. Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients;European Journal of Neurology;2022-06-07

4. Transforaminal lumbar puncture for intrathecal access: Case series with literature review and comparison to other techniques;Journal of Clinical Neuroscience;2020-02

5. Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1;Advances in Therapy;2019-03-16